Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1977-11-25
|
pubmed:language |
hrv
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0350-199X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
171-5
|
pubmed:dateRevised |
2009-11-9
|
pubmed:meshHeading |
pubmed-meshheading:333198-Adult,
pubmed-meshheading:333198-Aged,
pubmed-meshheading:333198-Cardiac Glycosides,
pubmed-meshheading:333198-Clinical Trials as Topic,
pubmed-meshheading:333198-Drug Evaluation,
pubmed-meshheading:333198-Female,
pubmed-meshheading:333198-Heart Failure,
pubmed-meshheading:333198-Humans,
pubmed-meshheading:333198-Male,
pubmed-meshheading:333198-Middle Aged
|
pubmed:articleTitle |
[Clinical evaluation of Talusin in the treatment of cardiac insufficiency].
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|